A therapeutic approach to pantothenate kinase associated neurodegeneration: a pilot study

A therapeutic approach to pantothenate kinase associated neurodegeneration: a pilot study

Abstract Background Neurodegeneration with brain iron accumulation (NBIA) is a group of genetic neurological disorders frequently associated with iron accumulation in the basal nuclei of the brain characterized by progressive spasticity, dystonia, muscle rigidity, neuropsychiatric symptoms, and reti...

Full description

Saved in:

Bibliographic Details
Main Authors:	Alessandra Pereira, Carolina Fischinger Moura de Souza, Mónica Álvarez-Córdoba, Diana Reche-López, José Antonio Sánchez-Alcázar
Format:	Article
Language:	English
Published:	BMC 2024-11-01
Series:	Orphanet Journal of Rare Diseases
Online Access:	https://doi.org/10.1186/s13023-024-03453-x
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Retinitis pigmentosa in pantothenate kinase-associated neurodegeneration
by: José Luiz Pedroso, et al.
Published: (2014-10-01)

PANK activators for the treatment of pantothenate kinase-associated neurodegeneration
by: Jessica Regan, Ph.D., et al.
Published: (2025-07-01)

Pathology and treatment methods in pantothenate kinase-associated neurodegeneration
by: Robert Kwinta, et al.
Published: (2024-07-01)

Serum metabolomics indicates ferroptosis in patients with pantothenate kinase associated neurodegeneration
by: Beata Toczylowska, et al.
Published: (2025-03-01)

Characterization of the Pank2-/- mouse retinal phenotype as a pre-clinical model for pantothenate kinase-associated neurodegeneration.
by: Grace Li-Na Su, et al.
Published: (2025-01-01)

Characterization of the Pank2-/- mouse retinal phenotype as a pre-clinical model for pantothenate kinase-associated neurodegeneration
by: Grace Li-Na Su, et al.
Published: (2025-01-01)

Phenotypes and Genotypes of Patients with Pantothenate Kinase-Associated Neurodegeneration in Asian and Caucasian Populations: 2 Cases and Literature Review
by: Chih-Hong Lee, et al.
Published: (2013-01-01)

Pantothenate kinase-associated neurodegeneration (Hallerworden–Spatze disease): clinical aspects, diagnosis, treatment (literature review and own data)
by: Yu. H. Antypkin, et al.
Published: (2021-10-01)

Pantothenate kinase 4 controls skeletal muscle substrate metabolism
by: Adriana Miranda-Cervantes, et al.
Published: (2025-01-01)

Pantothenate kinase-associated neurodegeneration (PKAN): molecular confirmation of a Turkish patient with a rare frameshift mutation in the coding region of the PANK2 gene
by: Hakan Cangül, et al.
Published: (2009-04-01)

Pyruvate kinase deficiency links metabolic perturbations to neurodegeneration and axonal protection
by: Thomas J. Waller, et al.
Published: (2025-08-01)

Amodiaquine drug pressure selects nonsynonymous mutations in pantothenate kinase 1, diacylglycerol kinase, and phosphatidylinositol-4 kinase in Plasmodium berghei ANKA [version 3; peer review: 1 approved, 3 approved with reservations, 1 not approved]
by: Peter Mwitari, et al.
Published: (2023-10-01)

Therapeutic targeting of obesity-induced neuroinflammation and neurodegeneration
by: Jialiu Zeng, et al.
Published: (2025-01-01)

Microglial senescence in neurodegeneration: Insights, implications, and therapeutic opportunities
by: Tobiloba Samuel Olajide, et al.
Published: (2024-09-01)

Gut-brain axis and neurodegeneration: mechanisms and therapeutic potentials
by: Kelly Jimin Park, et al.
Published: (2024-10-01)

Pantothenic acid ameliorates hepatic fibrosis by targeting IGFBP6 to regulate the TGF-β/SMADs pathway
by: Zhengxin Jin, et al.
Published: (2025-07-01)

Assessment of the feed additive consisting of calcium D‐pantothenate for all animal species for the renewal of its authorisation (BASF SE)
by: EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP), et al.
Published: (2024-07-01)

Editorial: Recent advances in mitochondrial dysfunction and therapeutics for neurodegeneration and aging
by: Monokesh K. Sen, et al.
Published: (2025-07-01)

Serum lipidomic analysis identifies potential therapeutic targets for neurodegeneration
by: Lumi Zhang, et al.
Published: (2025-06-01)

Pantothenate regulates feeding and reproduction in the malaria vector Anopheles stephensi, with patterns dependent on supplementation scheme and parental nutrition
by: Megan E. Dobson, et al.
Published: (2025-08-01)

Assessment of the feed additives calcium d‐pantothenate and d‐panthenol for all animal species for the renewal of their authorisation (DSM Nutritional products Ltd)
by: EFSA Panel on Additives and Products or Substances used in Animal Feed (FEEDAP), et al.
Published: (2025-02-01)

VdPAT1 encoding a pantothenate transporter protein is required for fungal growth, mycelial penetration and pathogenicity of Verticillium dahliae
by: Stephen Mwangi Kamau, et al.
Published: (2025-01-01)

Alterations in some haematological parameters, ascorbic acid and pantothenic acid levels among pregnant women with plasmodium parasitaemia in Sokoto, Nigeria
by: Sulaiman Sule Umar , Osaro Erhabor , Yakubu Abdulrahaman , Isaac Zama , Festus Uchechukwu Onuigwe , 1 1 2 Hauwa Buhari, Aliyu Bagudo , Ahmed Marafa , Tosan Erhabor
Published: (2022-11-01)

Non-coding RNAs as key players in neurodegeneration and brain tumors: Insights into therapeutic strategies
by: Mohamed Javad Saadh, et al.
Published: (2025-08-01)

Oxidative Stress in Neurodegeneration
by: Varsha Shukla, et al.
Published: (2011-01-01)

Neurodegeneration: 2024 update
by: John F. Crary
Published: (2024-12-01)

Tyrosine kinase as therapeutic target of neurodegenerative disorders
by: Dipanjan Karati, et al.
Published: (2025-03-01)

Neurodegeneration with brain iron accumulation
by: João Carlos Papaterra Limongi
Published: (2016-07-01)

From long COVID to neurodegeneration
by: Luis Del Carpio-Orantes
Published: (2025-01-01)

Editorial: Aging and neurodegeneration in the brain
by: F. Kerr, et al.
Published: (2025-04-01)

From imaging to intervention: emerging potential of PET biomarkers to shape therapeutic strategies for TBI-induced neurodegeneration
by: Anna O. Giarratana
Published: (2025-08-01)

Neurodegeneration models in Parkinson’s disease: cellular and molecular paths to neuron death
by: Diana D. Álvarez-Luquín, et al.
Published: (2025-05-01)

Neurodegeneration and aging pathways in Mucopolysaccharidosis IIIB
by: Yorran Hardman Araújo Montenegro
Published: (2025-07-01)

The Role of Tau in Neuronal Function and Neurodegeneration
by: Gonzalo Emiliano Aranda-Abreu, et al.
Published: (2025-05-01)

Radiation Retinopathy: Microangiopathy-Inflammation-Neurodegeneration
by: Anja-Maria Davids, et al.
Published: (2025-02-01)

Neurodegeneration: A Tale of Microbes and Neurons
by: Octavian Costin IOGHEN, et al.
Published: (2025-03-01)

Editorial: Aging, peripheral inflammation, and neurodegeneration
by: Caroline Haikal, et al.
Published: (2024-12-01)

DNA Damage, Neurodegeneration, and Synaptic Plasticity
by: Daniela Merlo, et al.
Published: (2016-01-01)

The role of Aha1 in cancer and neurodegeneration
by: Brian S.J. Blagg, et al.
Published: (2024-12-01)

Beyond neurodegeneration: engineering amyloids for biocatalysis
by: Andrea Bartolomé-Nafría, et al.
Published: (2025-10-01)